SWA
CLB icon

Sutton Wealth Advisors’s Core Laboratories CLB Stock Holding History

Sutton Wealth Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-913
Closed -$18.5K – 955
2022
Q4 		$18.5K Hold
913
– – 0.01% 725
2022
Q3 		$12.3K Buy
+913
New +$15.4K 0.01% 833
2022
Q2 		– Sell
-313
Closed -$9.9K – 1649
2022
Q1 		$9.9K Buy
313
+299
+2,136% +$8.38K ﹤0.01% 933
2021
Q4 		$312 Sell
14
-538
-97% -$14K ﹤0.01% 1597
2021
Q3 		$15.3K Buy
552
+171
+45% +$5.21K 0.01% 778
2021
Q2 		$14.8K Buy
+381
New +$13.7K 0.01% 786
2020
Q4 		– Sell
-283
Closed -$4.32K – 1235
2020
Q3 		$4.32K Buy
283
+23
+9% +$482 ﹤0.01% 964
2020
Q2 		$5.28K Buy
+260
New +$4.66K ﹤0.01% 862

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Sutton Wealth Advisors's CLB Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Core Laboratories (CLB) in Q1 2023, closing a stake of 913 shares — an estimated $18.5K sold.

Sutton Wealth Advisors first reported a position in CLB in Q2 2020 and held it in 8 quarters. The position peaked at $18.5K in Q4 2022. 163 funds tracked by Wall St. Rank hold CLB as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Core Laboratories position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 913 Core Laboratories shares in Q1 2023, an estimated $18.5K.
  • Sutton Wealth Advisors first reported a position in Core Laboratories in Q2 2020 and held it in 8 quarters.
  • Sutton Wealth Advisors's Core Laboratories position peaked at $18.5K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.